These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21959358)

  • 1. Quetiapine (Seroquel) and QT-interval prolongation.
    Med Lett Drugs Ther; 2011 Oct; 53(1374):79-80. PubMed ID: 21959358
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and analytical features of severe suicidal quetiapine overdoses--a retrospective cohort study.
    Eyer F; Pfab R; Felgenhauer N; Strubel T; Saugel B; Zilker T
    Clin Toxicol (Phila); 2011 Nov; 49(9):846-53. PubMed ID: 22077248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT interval prolongation associated with quetiapine (Seroquel) overdose.
    Gajwani P; Pozuelo L; Tesar GE
    Psychosomatics; 2000; 41(1):63-5. PubMed ID: 10665270
    [No Abstract]   [Full Text] [Related]  

  • 4. Quetiapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine.
    Vieweg WV; Schneider RK; Wood MA
    Acta Psychiatr Scand; 2005 Oct; 112(4):318-22; author reply 322. PubMed ID: 16156840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.
    Nemeroff CB; Kinkead B; Goldstein J
    J Clin Psychiatry; 2002; 63 Suppl 13():5-11. PubMed ID: 12562141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
    Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions.
    Pollak PT; Zbuk K
    Clin Pharmacol Ther; 2000 Jul; 68(1):92-7. PubMed ID: 10945320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine, an atypical antipsychotic.
    Goren JL; Levin GM
    Pharmacotherapy; 1998; 18(6):1183-94. PubMed ID: 9855315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In response to Furst et al, "Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin".
    Geller W; Smith M; Winter H; Brecher M
    Biol Psychiatry; 2002 Nov; 52(9):914; author reply 914-5. PubMed ID: 12399147
    [No Abstract]   [Full Text] [Related]  

  • 12. Priapism associated with routine use of quetiapine: case report and review of the literature.
    Davol P; Rukstalis D
    Urology; 2005 Oct; 66(4):880. PubMed ID: 16230163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine: novel uses in the treatment of depressive and anxiety disorders.
    Ravindran AV; Al-Subaie A; Abraham G
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1187-204. PubMed ID: 20795889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics.
    Pollak PT; Verjee ZH; Lyon AW
    J Clin Pharmacol; 2011 Jul; 51(7):1112-5. PubMed ID: 20663990
    [No Abstract]   [Full Text] [Related]  

  • 16. Quetiapine for sleep.
    Yost S; White J
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):53-5. PubMed ID: 20345201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA "black box" labeling.
    Meyer RJ
    Ann Emerg Med; 2003 Apr; 41(4):559-60. PubMed ID: 12658256
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary retention following repeated high-dose quetiapine.
    Sokolski KN; Brown BJ; Melden M
    Ann Pharmacother; 2004 May; 38(5):899-900. PubMed ID: 15039480
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
    Figueroa C; Brecher M; Hamer-Maansson JE; Winter H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):199-204. PubMed ID: 18948162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroquel, Serzone and seizures.
    Worthley DL; Burgess N; Nigro O; Shakib S
    Intern Med J; 2004 Mar; 34(3):134-5. PubMed ID: 15030464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.